190 related articles for article (PubMed ID: 32250211)
21. Regulatory Role of Quiescence in the Biological Function of Cancer Stem Cells.
Lee SH; Reed-Newman T; Anant S; Ramasamy TS
Stem Cell Rev Rep; 2020 Dec; 16(6):1185-1207. PubMed ID: 32894403
[TBL] [Abstract][Full Text] [Related]
22. [Progress in the study of targeted drug delivery systems for cancer stem cells].
Qiao MX; Zhang XJ; Shuang BA; Hu HY; Zhao XL; Chen DW
Yao Xue Xue Bao; 2013 Apr; 48(4):477-83. PubMed ID: 23833932
[TBL] [Abstract][Full Text] [Related]
23. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.
Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP
Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243
[TBL] [Abstract][Full Text] [Related]
24. Cancer Stem Cells and Targeting Strategies.
Barbato L; Bocchetti M; Di Biase A; Regad T
Cells; 2019 Aug; 8(8):. PubMed ID: 31426611
[TBL] [Abstract][Full Text] [Related]
25. Cancer stem cells: the 'Achilles heel' of chemo-resistant tumors.
Hong IS; Lee HY; Nam JS
Recent Pat Anticancer Drug Discov; 2015; 10(1):2-22. PubMed ID: 25479037
[TBL] [Abstract][Full Text] [Related]
26. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
27. Nanoparticles for Targeted Drug Delivery to Cancer Stem Cells and Tumor.
Wang H; He X
Methods Mol Biol; 2018; 1831():59-67. PubMed ID: 30051425
[TBL] [Abstract][Full Text] [Related]
28. A nano-based thermotherapy for cancer stem cell-targeted therapy.
Suo X; Zhang J; Zhang Y; Liang XJ; Zhang J; Liu D
J Mater Chem B; 2020 May; 8(18):3985-4001. PubMed ID: 32239013
[TBL] [Abstract][Full Text] [Related]
29. Nanocarrier-mediated drugs targeting cancer stem cells: an emerging delivery approach.
Malhi S; Gu X
Expert Opin Drug Deliv; 2015 Jul; 12(7):1177-201. PubMed ID: 25601619
[TBL] [Abstract][Full Text] [Related]
30. CD10
Ffrench B; Gasch C; Hokamp K; Spillane C; Blackshields G; Mahgoub TM; Bates M; Kehoe L; Mooney A; Doyle R; Doyle B; O'Donnell D; Gleeson N; Hennessy BT; Stordal B; O'Riain C; Lambkin H; O'Toole S; O'Leary JJ; Gallagher MF
Cell Death Dis; 2017 Oct; 8(10):e3128. PubMed ID: 29048400
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma.
Kumar D; Gorain M; Kundu G; Kundu GC
Mol Cancer; 2017 Jan; 16(1):7. PubMed ID: 28137308
[TBL] [Abstract][Full Text] [Related]
32. Phytonanomedicine: a novel avenue to treat recurrent cancer by targeting cancer stem cells.
Mohapatra P; Singh P; Sahoo SK
Drug Discov Today; 2020 Aug; 25(8):1307-1321. PubMed ID: 32554061
[TBL] [Abstract][Full Text] [Related]
33. [Cancer Stem Cells (CSCs) as a Rational Therapeutic Cancer Target, and Screening for CSC-targeting Drugs].
Mashima T
Yakugaku Zasshi; 2017; 137(2):129-132. PubMed ID: 28154319
[TBL] [Abstract][Full Text] [Related]
34. Delivering cancer stem cell therapies - a role for nanomedicines?
Schätzlein AG
Eur J Cancer; 2006 Jun; 42(9):1309-15. PubMed ID: 16682183
[TBL] [Abstract][Full Text] [Related]
35. A novel reporter construct for screening small molecule inhibitors that specifically target self-renewing cancer cells.
Shanmugam G; Mohan A; Kumari K; Louis JM; Soumya Krishnan U; Balagopal PG; George NA; Sebastian P; Maliekal TT
Exp Cell Res; 2019 Oct; 383(2):111551. PubMed ID: 31401066
[TBL] [Abstract][Full Text] [Related]
36. A novel double-targeted nondrug delivery system for targeting cancer stem cells.
Qiao S; Zhao Y; Geng S; Li Y; Hou X; Liu Y; Lin FH; Yao L; Tian W
Int J Nanomedicine; 2016; 11():6667-6678. PubMed ID: 27994463
[TBL] [Abstract][Full Text] [Related]
37. New approaches to target cancer stem cells: current scenario.
Insan MB; Jaitak V
Mini Rev Med Chem; 2014 Jan; 14(1):20-34. PubMed ID: 24195662
[TBL] [Abstract][Full Text] [Related]
38. Nanomedicine and chemotherapeutics drug delivery: challenges and opportunities.
Nezhadi S; Saadat E; Handali S; Dorkoosh F
J Drug Target; 2021 Feb; 29(2):185-198. PubMed ID: 32772739
[TBL] [Abstract][Full Text] [Related]
39. Cancer stem cells-emanated therapy resistance: Implications for liposomal drug delivery systems.
Dianat-Moghadam H; Heidarifard M; Jahanban-Esfahlan R; Panahi Y; Hamishehkar H; Pouremamali F; Rahbarghazi R; Nouri M
J Control Release; 2018 Oct; 288():62-83. PubMed ID: 30184466
[TBL] [Abstract][Full Text] [Related]
40. Cancer stem cells (CSCs), cervical CSCs and targeted therapies.
Huang R; Rofstad EK
Oncotarget; 2017 May; 8(21):35351-35367. PubMed ID: 27343550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
